Market revenue in 2019 | USD 19.1 million |
Market revenue in 2026 | USD 35.0 million |
Growth rate | 9% (CAGR from 2019 to 2026) |
Largest segment | Directional atherectomy |
Fastest growing segment | Laser atherectomy |
Historical data | 2015 - 2018 |
Base year | 2019 |
Forecast period | 2020 - 2026 |
Quantitative units | Revenue in USD million |
Market segmentation | Directional atherectomy, Rotational atherectomy, Orbital atherectomy, Laser atherectomy |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Koninklijke Philips NV, BD, Abbott Laboratories, Avinger Inc, Cardiovascular Systems, Cardinal Health Inc, Terumo Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atherectomy devices market will help companies and investors design strategic landscapes.
Directional atherectomy was the largest segment with a revenue share of 37.17% in 2019. Horizon Databook has segmented the Japan atherectomy devices market based on directional atherectomy, rotational atherectomy, orbital atherectomy, laser atherectomy covering the revenue growth of each sub-segment from 2015 to 2026.
Japan poses as an attractive market for atherectomy devices due to aging population and rising prevalence of the target diseases. This is supplemented by the country’s favorable regulatory policies. Industry players need to follow a two-step process to enter the Japanese market.
The companies need to gain approval from the Japan’s Pharmaceuticals and Medical Devices Agency for their medical devices. They are required to submit detailed product description, mechanism, technologies used, and evidence-based efficacy results. After receiving approval, they are required to sign an agreement with a distributor to distribute their products in the region.
One such recent agreement was signed between Cardiovascular Systems, Inc. and Medikit Co., Ltd. in November 2016. The agreement was to distribute its two products in Japan: Diamondback 360 Coronary and Peripheral Orbital Atherectomy Systems (OAS). The company had access to the 120 sales representatives distributing their products in 800 hospitals in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan atherectomy devices market, including forecasts for subscribers. This country databook contains high-level insights into Japan atherectomy devices market from 2015 to 2026, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account